Rhythm: therapies for the treatment of rare genetic disorders

Sep 8, 2019

Hi guys,

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity.

Long:

• LMT 1- 19.9$ (20 % of the planned investment amount)
  
  • LMT 2- 19.21$ (40 % of the planned investment amount)
    
    • LMT 3- 18,31$ (40 % of the planned investment amount)
      TP:31.4$
      
      
      Comments and likes are greatly appreciated.
      
      
      I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions and this is not a call for investment. I am not receiving compensation for it . I have no business relationship with any company whose stock is mentioned in this article.